KEY HIGHLIGHTS Oxford’s COVID-19 vaccine has shown encouraging results in early human trials ChAdOx1, to be called Covishield in India, is currently in the phase 3 trials across research facilities
KEY HIGHLIGHTS Oxford’s COVID-19 vaccine has shown encouraging results in early human trials ChAdOx1, to be called Covishield in India, is currently in the phase 3 trials across research facilities